Patient experience with antibody mediated rejection (AMR)
Please answer the two questions below if you have experience with antibody mediated rejection (AMR) as part of your transplant journey and are willing to participate on a Patient Advisory Board. We are working with a company that would like to hear directly from patients to better understand the journey with AMR, to learn what matters most when seeking care options, and to understand patients' familiarity with clinical research. Please answer these questions if you think you may be a candidate.
Tell us about your experience with antibody mediated rejection (AMR)
The American Kidney Fund is working with a company that is seeking people who have lived experience with antibody mediated rejection (AMR) as part of their transplant journey to join a Patient Advisory Board. They would like to hear directly from patients to better understand the journey with AMR, to learn what matters most when seeking care options, and to understand patients' familiarity with clinical research. If selected, this will be a two to three hour time commitment and participants will be compensated for their time.
Note: The objective is to ensure that the patient voice and perspective is included in relevant clinical research planning and development. This opportunity is not directly sponsored by the American Kidney Fund.
